Trends in Biochemical Sciences
Multifaceted roles of glycolytic enzymes
Introduction
Before the existence of atmospheric oxygen, anaerobic glucose metabolism involving glycolysis evolved to produce energy for ancient anaerobic life forms. The glycolytic pathway and its enzymes, which convert glucose to pyruvic acid using the oxidative potential of NAD+, are among the most ancient molecular metabolic networks [1] (Box 1). In the absence of oxygen, NAD+ is regenerated from reduced NADH by the conversion of pyruvate to lactic acid. Glycolysis has been highly conserved among species, even after the emergence of atmospheric oxygen, which provided a means to further oxidize pyruvate by oxidative phosphorylation, resulting in a high yield of energy. Although ambient expression of glycolytic enzymes is necessary for steady-state glucose metabolism, the coordinated increased expression of genes encoding glycolytic enzymes is particularly important for adaptation to hypoxia. The hypoxia-inducible transcription factor HIF-1, which is stabilized by hypoxia, induces almost all the genes encoding glycolytic enzymes 2, 3, 4, 5, 6. With oxygen depletion, the unmodified, stable HIF-1α in a heterodimer binds cis-regulatory elements to activate hypoxia-responsive genes including those encoding many glycolytic enzymes 7, 8.
In contrast to normal cells that increase glycolysis in response to hypoxia, cancer cells undergo glycolysis with increased lactate production even in the presence of oxygen. This phenomenon in cancer cells is termed the Warburg effect. In 1929, it was hypothesized that the reliance of cancer cells on glycolysis results from defective tumor mitochondria that could not mediate normal oxidative metabolism [9]. Although the exact mechanisms contributing to the Warburg effect are still under scrutiny, it is known that micro-environmental tumor hypoxia and oncogenic activation of Akt and Myc can enhance glycolysis by non-transcriptional and transcriptional mechanisms 10, 11, 12. Furthermore, HIF-1α might be stabilized independently of hypoxia via loss of vHL (von Hippel–Lindau protein), a tumor suppressor and a component of the proteasomal degradation pathway, or via non-hypoxic signal-transduction pathways 5, 13. These observations indicate that both cell autonomous, oncogenic signals and micro-environmental hypoxia contribute to the high rates of tumor glycolysis.
Most early structural and functional investigations of glycolytic enzymes have focused on their glycolytic functions. However, with the precedence of aconitase – a tricarboxylic-acid-cycle enzyme – having a role in the regulation of iron metabolism by binding RNA hairpin loops, it is perhaps not surprising that glycolytic enzymes might participate in other cellular processes 14, 15. In fact, recent studies have provided evidence that some glycolytic enzymes are more complicated, multi-functional proteins rather than simple components of the glycolytic pathway. As shown in Table 1, unexpected functional roles of several glycolytic enzymes have been identified. These new functions include transcriptional regulation [hexokinase (HK)-2, lactate dehydrogenase (LDH)-A, glyceraldehyde-3-phosphate dehydrogenase (GAPD) and enolase (ENO) 1], apoptosis (HK and GAPD) and cell motility [glucose-6-phosphate isomerase (GPI)]. Furthermore, in yeast, the mitochondrial metabolic enzyme Arg5,6 binds both nuclear and mitochondrial DNA, and seems to regulate nuclear and mitochondrial target genes [16]. Thus, it is important to reevaluate and recognize the roles for glycolytic enzymes in other biological processes, in particular, because glycolytic enzymes are usually regarded as boring ‘housekeeping’ proteins that exist only to fuel more important, intriguing biochemical processes. Here, the evidence supporting the unexpected multi-functional roles for the glycolytic proteins are reviewed with the hope that interpretation of data pertaining to the expression of glycolytic enzymes also considers their non-glycolytic functions.
Section snippets
Transcriptional regulation
The unexpected nuclear localization of several glycolytic enzymes, including LDH, GAPD and ENO1, was noted in several early studies. Several studies provided convincing evidence that nuclear forms of these glycolytic enzymes participate in transcription and/or DNA replication. In this section, evidence of the unexpected roles for nuclear glycolytic enzymes in transcription will be discussed.
Apoptosis
Apoptosis, similar to glycolysis, is a highly conserved, finely regulated, multi-step process for maintaining cellular homeostasis in metazoans by programmed cell death. It stands to reason that cellular homeostasis is partly dependent on energy status and, hence, apoptosis might be dependent on glucose metabolism. Based on numerous studies demonstrating that glucose metabolism is implicated in cell death and survival, it is reasonable to speculate that these two crucial processes – glycolysis
GPI and cell motility
The second glycolytic step, the isomerization of glucose-6-phosphate (G6P) to fructose-6-phosphate is carried out by GPI. In addition to its role in glycolysis, recent studies have revealed that GPI is also an autocrine motility factor (AMF) [80]. AMF and its receptor AMFR (gp78) were originally identified in melanoma and oncogene-transfected metastatic NIH3T3 cells [81]. GPI is secreted from the tumor cells and promotes cell motility and proliferation in an autocrine manner [82]. Tumor cells
Concluding remarks
Numerous studies have provided intriguing evidence of the unexpected nature of glycolytic enzymes that is beginning to change the conventional concepts of simple roles of these ancient proteins. However, little is known about the molecular mechanisms of the multifaceted roles of glycolytic enzymes, specifically regarding the relationship between their glycolytic and non-glycolytic functions. As is the case for hexokinase, the glycolytic pathway is efficiently integrated with the mitochondrial
Acknowledgements
We apologize for inadvertent omission of any pertinent original references owing to space limitations. Our original work was supported in part by NIH grants CA51497 (C.V.D.), CA57341 (C.V.D.). J-W. K. is a Howard Hughes Medical Institute Predoctoral Fellow. C.V.D. is the Johns Hopkins Family Professor in oncology research. We thank L. Lee and K. O'Donnell for helpful comments.
References (93)
- et al.
HIF-1 and hypoxic response: the plot thickens
Curr. Opin. Genet. Dev.
(2004) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1
J. Biol. Chem.
(1996)Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1
J. Biol. Chem.
(1994)- et al.
Oncogenic alterations of metabolism
Trends Biochem. Sci.
(1999) - et al.
The von Hippel–Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis
Trends Mol. Med.
(2004) Structural relationship between an iron-regulated RNA-binding protein (IRE-BP) and aconitase: functional implications
Cell
(1991)The hexokinase 2 protein participates in regulatory DNA-protein complexes necessary for glucose repression of the SUC2 gene in Saccharomyces cerevisiae
FEBS Lett.
(1998)The glucose-regulated nuclear localization of hexokinase 2 in Saccharomyces cerevisiae is Mig1-dependent
J. Biol. Chem.
(2004)Mediator factor Med8p interacts with the hexokinase 2: implication in the glucose signalling pathway of Saccharomyces cerevisiae
J. Mol. Biol.
(2002)Nuclear localization of a lactic dehydrogenase with single-stranded DNA-binding properties
Exp. Cell Res.
(1985)
S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component
Cell
Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro
J. Biol. Chem.
Identification of the NAD(+)-binding fold of glyceraldehyde-3-phosphate dehydrogenase as a novel RNA-binding domain
Biochem. Biophys. Res. Commun.
Study of the interaction of glyceraldehyde-3-phosphate dehydrogenase with DNA
Biochim. Biophys. Acta
New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase
Biochim. Biophys. Acta
Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase
J. Biol. Chem.
Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and LA protein with cis-acting RNAs of human parainfluenza virus type 3
J. Biol. Chem.
Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5′-nontranslated RNA of hepatitis A virus
J. Biol. Chem.
Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase
J. Mol. Biol.
Lactate dehydrogenase is an AU-rich element-binding protein that directly interacts with AUF1
J. Biol. Chem.
Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold)
J. Biol. Chem.
Minireview. Emerging new functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells
Life Sci.
Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene
J. Biol. Chem.
MBP-1 physically associates with histone deacetylase for transcriptional repression
Biochem. Biophys. Res. Commun.
ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1)
FEBS Lett.
Enolase, a cellular glycolytic enzyme, is required for efficient transcription of Sendai virus genome
Biochem. Biophys. Res. Commun.
Glucose phosphorylation in tumor cells. Cloning, sequencing, and overexpression in active form of a full-length cDNA encoding a mitochondrial bindable form of hexokinase
J. Biol. Chem.
Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death
J. Biol. Chem.
Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis
J. Biol. Chem.
A novel CRM1-mediated nuclear export signal governs nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase following genotoxic stress
J. Biol. Chem.
Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl
J. Biol. Chem.
Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins
Hepatology
The enzymatic activity of phosphoglucose isomerase is not required for its cytokine function
FEBS Lett.
Potential endocrine function of the glycolytic enzyme glucose-6-phosphate isomerase during implantation
Gen. Comp. Endocrinol.
The global phylogeny of glycolytic enzymes
Proc. Natl. Acad. Sci. U. S. A.
Oxygen sensing by HIF hydroxylases
Nat. Rev. Mol. Cell Biol.
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein
Nat. Cell Biol.
VHL takes HIF's breath away
Nat. Cell Biol.
Targeting of HIF-α to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
Science
On the origin of cancer cells
Science
Akt stimulates aerobic glycolysis in cancer cells
Cancer Res.
Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays
Mol. Cell. Biol.
A regulated RNA binding protein also possesses aconitase activity
Proc. Natl. Acad. Sci. U. S. A.
Regulation of gene expression by a metabolic enzyme
Science
Glucose repression in the yeast Saccharomyces cerevisiae
Mol. Microbiol.
Physiological properties of Saccharomyces cerevisiae from which hexokinase II has been deleted
Appl. Environ. Microbiol.
Cited by (535)
Relevance of microbial glucokinases
2023, Biotechnology of Microbial Enzymes: Production, Biocatalysis, and Industrial Applications, Second Edition